Company Overview and News
Stop missing out on important events!
Rhinomed Ltd (ASX:RNO) has completed a $3.6 million share placement to institutional and sophisticated investors at $0.15 per share.
Rhinomed Ltd (ASX:RNO) has signed a distribution agreement with Brojaw Inc., to begin distributing its snoring and nasal breathing product Mute into the Taiwanese market.
Rhinomed (ASX:RNO) has undertaken a $2.1 million private placement to two U.S. based sophisticated investor groups to fund its retail distribution expansion.
Rhinomed (ASX:RNO) has been granted a trading halt by the ASX, pending details of a capital raising.
MELBOURNE, Australia, Dec. 7, 2016 /PRNewswire/ -- Australian innovator Rhinomed (ASX:RNO) is seeking to transform the way consumers view sleep by teaming up with sleep giant The Linde Group through its subsidiary BOC Limited.
MELBOURNE, Australia, May 31, 2016 /PRNewswire/ -- Rhinomed LTD (ASX:RNO), an Australian nasal and respiratory technology company, is pleased to announce the U.S. debut of its Mute snoring and sleep technology. All four Mute packs (trial, small, medium and large) are now available in select Walgreens and Duane Reade stores across the U.S., including approximately 100 of the chain's locations throughout Manhattan, New York.